T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Schlumberger
SLB
|
+$2.5B |
| 2 |
Kenvue
KVUE
|
+$1.3B |
| 3 |
Halliburton
HAL
|
+$1.16B |
| 4 |
Charles Schwab
SCHW
|
+$836M |
| 5 |
Boeing
BA
|
+$832M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.52B |
| 2 |
Apple
AAPL
|
+$1.77B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.57B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.47B |
| 5 |
Intuit
INTU
|
+$1.14B |
Sector Composition
| 1 | Technology | 29.85% |
| 2 | Healthcare | 16.84% |
| 3 | Financials | 10.89% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Labcorp
LH
$22.7B
| $23.6M | ﹤0.01% |
117,234
-19,720
| -14% | -$3.96M |
|
877
Prestige Consumer Healthcare
PBH
$3.2B
| $23.3M | ﹤0.01% |
407,303
+2,027
| +0.5% | +$116K |
|
878
Allegion
ALLE
$14.6B
| $23.3M | ﹤0.01% |
223,526
+12,390
| +6% | +$1.29M |
|
879
PPL Corp
PPL
$26.5B
| $23.2M | ﹤0.01% |
984,025
-2,739
| -0.3% | -$64.5K |
|
880
Clorox
CLX
$15.1B
| $23.2M | ﹤0.01% |
176,655
-2,377
| -1% | -$312K |
|
881
Academy Sports + Outdoors
ASO
$3.21B
| $23M | ﹤0.01% |
486,654
-106,422
| -18% | -$5.03M |
|
882
Diageo
DEO
$57.9B
| $23M | ﹤0.01% |
154,202
-25,248
| -14% | -$3.77M |
|
|
RYZB
883
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $22.9M | ﹤0.01% |
+1,033,578
| New | +$22.9M |
|
884
Grupo Aeroportuario del Sureste
ASR
$10.1B
| $22.9M | ﹤0.01% |
93,320
-1,281
| -1% | -$315K |
|
885
A.O. Smith
AOS
$10.2B
| $22.8M | ﹤0.01% |
345,365
+366
| +0.1% | +$24.2K |
|
886
Jacobs Solutions
J
$17.3B
| $22.6M | ﹤0.01% |
200,592
-3,957
| -2% | -$447K |
|
887
HEICO
HEI
$44.1B
| $22.3M | ﹤0.01% |
137,931
+2,753
| +2% | +$446K |
|
888
Agilysys
AGYS
$3.03B
| $22.3M | ﹤0.01% |
336,642
+17,305
| +5% | +$1.14M |
|
|
MRO
889
DELISTED
Marathon Oil Corporation
MRO
| $22.2M | ﹤0.01% |
828,829
-14,864
| -2% | -$398K |
|
890
Evertec
EVTC
$2.14B
| $22.1M | ﹤0.01% |
594,190
+79,184
| +15% | +$2.94M |
|
891
Cooper Companies
COO
$13.5B
| $22.1M | ﹤0.01% |
277,716
-604,912
| -69% | -$48.1M |
|
892
Caesars Entertainment
CZR
$5.33B
| $22M | ﹤0.01% |
475,679
-4,921
| -1% | -$228K |
|
893
Nasdaq
NDAQ
$54.3B
| $21.9M | ﹤0.01% |
450,291
-5,380
| -1% | -$261K |
|
894
CureVac
CVAC
$1.21B
| $21.8M | ﹤0.01% |
3,187,699
-376,327
| -11% | -$2.57M |
|
895
Valvoline
VVV
$5B
| $21.7M | ﹤0.01% |
674,127
-782,225
| -54% | -$25.2M |
|
|
NIMC
896
DELISTED
NiSource Inc. Series A Corporate Units
NIMC
| – | – |
0
| – | -$95.3M |
|
897
Element Solutions
ESI
$6.24B
| $21.6M | ﹤0.01% |
1,102,423
-30,723
| -3% | -$603K |
|
898
Reinsurance Group of America
RGA
$12.7B
| $21.6M | ﹤0.01% |
148,896
+67,979
| +84% | +$9.87M |
|
899
Principal Financial Group
PFG
$17.8B
| $21.5M | ﹤0.01% |
298,732
-5,545
| -2% | -$400K |
|
900
Privia Health
PRVA
$2.78B
| $21.5M | ﹤0.01% |
935,017
-21,164
| -2% | -$487K |
|